The post names three groups: people with significant comorbidities, people who have had side effects on similar medications before, and people whose clinical situation calls for faster advancement than an entry protocol allows
Insurance providers recognize bariatric surgery as: Medically necessary for qualifying patients Cost-effective over time Supported by decades of outcomes data For patients frustrated by denials or escalating costs of GLP-1 medications, bariatric surgery may represent a more predictable and sustainable insurance-approved option
Age, baseline joint health, genetic predisposition to inflammatory response, and speed of weight loss all influence individual risk
There is ongoing investigation into potential effects on bone density and thyroid tissue, consistent with theoretical class signals observed with other agents
Ben Lagha I, Ashack K, Khachemoune A
Thus, you may still experience high blood sugar levels while you take the medication